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Edited by Gianni CesareniAbstract Activation of the receptor tyrosine kinase DDR1 by
collagen results in robust and sustained phosphorylation, how-
ever little is known about its downstream mediators.
Using phosphopeptide mapping and site-directed mutagenesis,
we here identiﬁed multiple tyrosine phosphorylation sites within
DDR1. We found that Nck2 and Shp-2, two SH2 domain-
containing proteins, bind toDDR1 in a collagen-dependentmanner.
The binding site of Shp-2 was mapped to tyrosine-740 of DDR1
within an ITIM-consensus sequence. Lastly, ablation of DDR1
in the mouse mammary gland resulted in delocalized expression
of Nck2, suggesting that defects observed during alveologenesis
are caused by the lack of the DDR1–Nck2 interaction.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Discoidin domain receptor 1 (DDR1) is a member of the
receptor tyrosine kinase (RTK) superfamily and is distin-
guished by a discoidin-homology region in its extracellular
portion. Uniquely, DDR1 is not a receptor for soluble
growth factors but for native, triple-helical collagens, in par-
ticular type I to type IV collagens [28,35,38]. DDR1 is expressed
in a number of tissues, including the mammary gland epithe-
lium [40]. The knockout of DDR1 showed an essential role in
postnatal mammary gland development and in the formation
of lactogenic tissue. In DDR1-null females, pubertal mam-
mary gland outgrowth is delayed and matrix deposition en-
hanced [40]. At parturition, knockout females failed to
nourish their litter due to the absence of alveolar opening
and milk protein secretion. Transplantation experiments of
knockout mammary tissue into the cleared fat pad of a wild
type recipient revealed that the defect in DDR1-null mice is
cell-autonomous [9]. While the absence of lactation is the
most striking defect in DDR1-knockout mice, we also docu-
mented aberrant formation of the renal basement membrane
and reduced signaling capacity of knockout mesangial cells
[8,11]. Additionally, smooth-muscle cells isolated from*Corresponding author. Fax: +1 416 978 5959.
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doi:10.1016/j.febslet.2005.11.035DDR1-null mice show reduced migration and chemotaxis
compared to control cells [12,13].
A more complete understanding of the DDR1 signaling
pathway is complicated by: (i) shedding of the extracellular do-
main; (ii) by alternative splicing of the DDR1 gene leading to
at least 5 distinct isoforms [1,2,39]. The DDR1c isoform is the
longest, while DDR1b lacks six amino acids in the kinase re-
gion, and exon 11 coding for 37 amino acids in the juxtamem-
brane region is absent in DDR1a. DDR1d and DDR1e are
truncated receptors missing the entire kinase domain or parts
of it, respectively. Previous work showed that the sequence en-
coded by the alternatively spliced exon 11 present in DDR1b/c
isoforms contains an LLXNPXpY-motif, which functions as
docking site for the ShcA adaptor molecule [35]. In human
breast cancer cells, ShcA was found to bind to DDR1b upon
activation by collagen; while in colon carcinoma cells, signal-
ing between activated DDR1 and p53 was found [25,35]. Fur-
thermore, in macrophages and in bronchoalveolar ﬂuid cells,
the recruitment of ShcA by DDR1b resulted in p38 MAPK
and NFjB activation through the TRAF6 pathway [20,21].
However, a detailed knowledge of other substrates and their
mode of interaction downstream of DDR1 are still missing.
In particular, the role of individual phosphotyrosines in
recruiting speciﬁc DDR1 substrates is largely unexplored.
Using a two hybrid-based screen and a phospho-site analy-
sis, we show here that Nck2 and Shp-2 bind to the cytoplasmic
region of DDR1 upon collagen engagement.2. Materials and methods
2.1. Plasmids, cell lines and antibodies
Cloning and expression of the human cDNAs coding for DDR1 and
Shp-2 were described previously [2,36]. Full-length Nck2 was ampliﬁed
from a human breast cancer library and cloned into the mammalian
expression vector pRK5. The QuickChange site-directed mutagenesis
kit (Stratagene) was used to introduce single point mutations into
FLAG-tagged DDR1 (Y484F, Y703F and Y740F, numbering refers
to full-length DDR1b including its signal peptide) and into Shp-2
(C463A). All constructs were sequenced to verify the presence of the
respective mutation. Primer sequences used for site-directed mutagen-
esis are available upon request.
Human embryonic kidney ﬁbroblast 293 cells and the breast cancer
cell lines MDA-MB-231, MCF-7 and T-47D were from ATCC and cul-
tivated as recommended by the supplier. Breast cancer cells were trans-
fected with the plasmid pIRES (BD Biosciences) containing full-length
DDR1. The following antibodies were used: Nck2 and anti-phosphoty-
rosine 4G10 (Upstate Biotechnologies Inc.), Shp-2 (BD Transduction
Laboratories), FLAG (Sigma), and DDR1 (C-terminal epitope fromblished by Elsevier B.V. All rights reserved.
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were Cy-3- (Jackson Immuno Research Laboratories) or Alexa 488-
(Molecular Probes) coupled.
2.2. Bacterial two-hybrid screen
We used a commercially available kit (Bacteriomatch II, Stratagene),
which is based on work published earlier [16]. The cytoplasmic domain
of DDR1 (amino acids 431–913) was cloned into the vector pBT in
frame with the bacteriophage lambda cI repressor. Overexpression of
DDR1 in bacteria resulted in activation of the tyrosine kinase function,
as measured by anti-phosphotyrosine blot of bacterial lysates. Compe-
tent bacteria were transformed with pBT-DDR1 and a human breast
cancer library cloned in frame with the RNA polymerase a into the vec-
tor pTRG (Stratagene). Interacting clones were identiﬁed by plating on
3-aminotriazole selection medium [16]. A more detailed summary of the
clones identiﬁed in this screen will be published elsewhere.
2.3. Cell transfection and Western blot analysis
Protein analysis was performed as previously published [35]. Brieﬂy,
human embryonic kidney 293 cells were transfected with 20 lg of
DNA per 10 cm dish using the calcium phosphate transfection proce-
dure. The medium was replaced with serum-free DMEM 18 h after
transfection. Twenty-four hours post-transfection, cells were stimu-
lated with 10 lg/ml rat type I collagen (BD Biosciences). Ninety min-
utes after stimulation, cells were lysed using a Triton-based lysis buﬀer
(50 mM Tris, pH 7.5, 1% Triton X-100, 150 mM NaCl, 0.5 mM
EDTA, 0.5 mM MgCl2, 10 mM NaF, 1 mM PMSF, 1 mM Na-ortho-
vanadate, and 10 mg/ml aprotinin). Lysates were diluted 1:1 (v/v) in
HNTG buﬀer (20 mM HEPES, pH 7.5, 150 mM NaCl, 0.1% Triton
X-100, 10% glycerol) and incubated with primary antibody coupled
to protein A Sepharose beads (Amersham) for 3 h. Beads were washed
four times with HNTG buﬀer and denatured in Laemmli buﬀer
(187.5 mM Tris, pH 6.8, 6% SDS, 30% glycerol, 0.01% bromophenol
blue, 15% 2-mercaptoethanol). Proteins were separated on 7.5% poly-
acrylamide gels and subjected to Western blotting. For 2D-gel electro-
phoresis, the ZOOM-IPG Runner-system (Invitrogen) was used.
1 · 106 cells were lysed and the resulting lysates separated in the ﬁrst
dimension by isoelectric focusing (pH 3–10) and in the second dimen-
sion on a 4–12% gradient gel. Gels were stained with SilverQuest
(Invitrogen).
2.4. Phosphopeptide analysis
A detailed protocol was published earlier [37]. Brieﬂy, 293 cells
transfected with DDR1 were labeled with [32P]-orthophosphate
(0.5 mCi/ml, Amersham) in phosphate-free DMEM for 4 h. Labeled
DDR1 was isolated by immunoprecipitation followed by SDS–PAGE
and Western blot transfer. Gels were incubated in alkali buﬀer (1 M
KOH, 55 C, 2 h) to remove serine- and threonine phosphorylation.
Bands were detected by autoradiography, subjected to tryptic digest
and analyzed by thin-layer chromatography, in the ﬁrst dimension
by electrophoresis at pH 1.9 and in the second dimension by ascending
chromatography.
2.5. Immunoﬂuorescence
Generation and characterization of DDR1 knockout mice were pub-
lished earlier [40]. Five lm paraﬃn embedded mouse mammary gland
tissue sections were cleared using xylene and rehydrated through an
ethyl alcohol series. Next, sections were rinsed with PBS, blocked with
2% goat or donkey serum in PBS, and incubated with primary anti-
bodies to Shp-2 (1:400) or Nck2 (1:200) overnight at 4 C. Sections
were washed again with PBS, incubated with secondary antibodies
coupled with Cy3 or Alexa-488 (1:800) and Hoechst (1:20000) for
1 h at room temperature, washed with PBS and mounted with cover-
slips using Mowiol. F-actin staining was performed with rhodamine
phalloidin. Image acquisition and analyses of the mammary tissue sec-
tions were performed using Zeiss Axioplan2 ﬂuorescence or LSM 510
confocal microscopes. To achieve highest contrast, images were taken
with a monochromatic camera and no false-color added.
2.6. GST fusion protein pull downs
The following primers were used to clone the Nck2–GST fusion pro-
teins into the plasmid pGEX-2T: SH2 forward, GCGGATCCCCAC-
AGATAAGCTACACC; SH2 reverse, GCGAATTCTCACTGCAG-GGCCCTGACG; 3SH3 forward, GCGGATCCACAGAAGAAGT-
TATTGTG; 3SH3 reverse, GCGAATTCTCAACTGAGGACCAC-
CACGTAG. The GST-fusion proteins were expressed in DH5a
bacteria using 0.01 mM IPTG for 3 h. Proteins were bound to glutathi-
one-beads (Clontech, BD Biosciences) and its integrity veriﬁed by Coo-
massie staining of SDS-gels. Equal amounts of fusion protein were
incubated with lysates from DDR1 overexpressing 293 cells. GST-
beads were washed four times with HNTG-buﬀer to remove non-
speciﬁc bound protein. Bound protein was detected by Western
blotting with an anti-DDR1 antibody.3. Results
Activation of the DDR1 tyrosine kinase function by colla-
gen causes robust and sustained autophosphorylation [35]. In
order to determine the extent of tyrosine phosphorylation of
the two most common isoforms, DDR1a and DDR1b, we la-
beled human embryonic kidney ﬁbroblast 293 cells expressing
DDR1a or DDR1b with [32P]-orthophosphate. Upon receptor
activation, DDR1 protein was isolated by immunoprecipita-
tion and subjected to trypsin digestion. Tryptic peptides of
DDR1a and DDR1b were resolved by two-dimensional thin-
layer chromatography. Seven [32P]-phosphate-labeled peptides
were found for DDR1a, and an additional three spots for the
b-isoform (Fig. 1A). A mix of equal amounts of both isoforms
allowed us to conﬁrm the identity of each spot in the two sam-
ples. We found peptides numbered as 1, 3 and 9 to be major
sites of autophosphorylation. Because peptides 8–10 were only
found in the b-isoform and not in the a-isoform, they are most
likely located within the alternatively spliced insert. Peptide 1
is more strongly phosphorylated in DDR1a than DDR1b sug-
gesting an isoform-speciﬁc mechanism of kinase function.
These results indicate that DDR1 undergoes multiple tyrosine
phosphorylation events upon kinase activation thereby open-
ing up several potential substrate-docking sites.
As a basis for the DDR1 substrate identiﬁcation approach
detailed below, we ﬁrst set out to perform 2D-gel electropho-
resis with lysates isolated from collagen-stimulated human
breast cancer MDA-MB-231 cells overexpressing DDR1 (b-
isoform). This allowed us to determine whether DDR1 is not
only capable of autophosphorylation but also phosphorylation
of intracellular proteins. Two-dimensional gels were run in
duplicate and subjected either to silver staining or Western blot
transfer (Fig. 1B and C). Analysis by anti-phosphotyrosine
Western blotting revealed several tyrosine phosphorylated pro-
teins, particularly in the range of 28–75 kDa, which most likely
resemble downstream signaling mediators of activated DDR1
(Fig. 1C). In contrast, control lysates from unstimulated cells
gave no distinct spots by anti-phosphotyrosine Western blot
analysis (not shown).
Based on these results, we set out to identify and molecularly
characterize proteins downstream of DDR1. We performed a
modiﬁed two-hybrid screen, where the bait and the target li-
brary were expressed in bacteria [16]. Fusing the intracellular
domain of DDR1 to the bait protein and overexpression in bac-
teria resulted in activation of the kinase function (Fig. 2A). The
DDR1-bait fusion was used to screen a pre-made human breast
cancer library. From the number of clones identiﬁed in this
screen, we focused on clone D1-8, which showed strong homol-
ogy to the adapter protein Nck2 (previously also named Grb4
or Nck-b). Detailed sequence comparison revealed that this
clone contained the complete coding sequence of the SH2
Fig. 1. Two-dimensional analysis of DDR1 receptor and substrate phosphorylation. (A) Human embryonic kidney ﬁbroblast 293 cells were
transfected with plasmids coding for DDR1a or DDR1b and labeled with [32P]-orthophosphate overnight. Following activation of the kinase, DDR1
protein was digested with trypsin and peptides resolved by two-dimensional thin layer chromatography. The autoradiograms with the phospho-
peptide pattern of DDR1a (left), DDR1b (center) and a mix of both isoforms (right) are shown. (B, C) Human breast cancer MBA-MB-231 cells
transfected with DDR1b were stimulated with collagen and cell lysates separated by 2D-gel electrophoresis and silver-stained (B). Anti-
phosphotyrosine Western blotting identiﬁed a distinct set of proteins as potential DDR1 substrates (C).
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380), but lacked the 3 N-terminal SH3 domains (Fig. 2A). Be-
cause the interaction was found in bacterial cells using only the
cytoplasmic region of DDR1, we next tested whether this inter-
action also takes place with full-length DDR1 expressed in
mammalian cells and whether the kinase function is regulated
by ligand binding. Lysates from 293 cells overexpressing
DDR1 were mixed with GST-fusion proteins containing full-
length Nck2, the three SH3 domains, or the SH2 domain.
Western blot analysis of bound protein revealed that DDR1
associates with the SH2 domain of Nck2 and to a weaker extent
with full-length Nck2, but not with the SH3 domain- or control
GST-proteins (Fig. 2B). This interaction was strictly phospho-
tyrosine-dependent, since DDR1 from cells not stimulated with
collagen failed to bind to any of the constructs. To verify that
DDR1 and Nck2 interact in live cells, we performed co-immu-
noprecipitation experiments using human breast tumor cells
expressing Flag-tagged DDR1. We found that endogenously
expressed Nck2 binds to DDR1 in a collagen-dependent man-
ner, whereas no binding was detected in control-transfected
cells (Fig. 2C). We were unable to demonstrate binding of
endogenous DDR1 and Nck2, because an antibody that specif-
ically immunoprecipitates non-epitope-tagged DDR1 from cell
lysates is not available.
Next, we scanned the DDR1 cytoplasmic sequence for po-
tential other SH2 domain binding sites (Fig. 3A). Most prom-
inently, we found Y740 (I-S-Y-P-M-L) to closely match the
consensus sequence I/V/L-X-Y-I/V-X-I/V/L for the SH2 do-
main containing phosphotyrosine phosphatase Shp-2 [14,36].
To test whether Shp-2 interacts with DDR1 in living cells,we overexpressed both proteins in 293 cells and used co-immu-
noprecipitation to show collagen-dependent binding of Shp-2
to DDR1 (Fig. 3B). Importantly, we found that Shp-2 indeed
utilized Y740 of DDR1b as an anchoring site. While mutations
of the non-relevant sites Y484 or Y703 had no eﬀect on the
complex formation between DDR1 and Shp-2, elimination
of Y740 by mutation to phenylalanine completely abolished
binding (Fig. 4A). Interestingly, some Shp-2 protein bound
to non-phosphorylated DDR1 when we immunoprecipitated
with an antibody for DDR1 (Fig. 4A), but not with an anti-
body for Shp-2 (Fig. 3B). This could be either due to diﬀeren-
tial aﬃnities of the antibodies recognizing the DDR1/Shp-2
complex in lysates or on a Western blot or due to a so far unex-
plored intrinsic property of the DDR1/Shp-2 complex.
It is well established that Shp-2 can function as a substrate
for several RTK, such as PDGF or EGFR [23,36]. To test
whether DDR1 recognizes Shp-2 as its substrate, we overex-
pressed a catalytically inactive Shp-2 mutant together with
DDR1b in 293 cells [31]. Immunoprecipitation of Shp-2 fol-
lowed by anti-phosphotyrosine Western blotting revealed a
DDR1 activation-dependent phosphorylation of catalytically
inactive Shp-2 (Fig. 4B). Notably, we neither detected phos-
phorylation of the catalytically inactive mutant in the absence
of co-transfected DDR1 (data not shown), nor of wild type
Shp-2 in the experiments displayed in Fig. 3B, which suggests
that Shp-2 regulates its own state of phosphorylation. Lastly,
we conﬁrmed the interaction of DDR1 with endogenous
Shp-2 in MCF-7 cells and found that higher amounts of
Shp-2 bound to collagen-activated DDR1, than to DDR1 in
unstimulated cells (Fig. 4C).
Fig. 2. Nck2 directly binds to DDR1 in an SH2-domain-dependent manner. (A) Schematic representation of the DDR1 bait used in the two-hybrid
screen and the target molecule Nck2. (B) A GST pull-down experiment with the SH2 domain, the three SH3 domains or full-length Nck2 revealed
that DDR1 requires the SH2 domain for binding. (C) DDR1-expressing MCF-7 cells and control cells were stimulated with type I collagen for 90 min
and DDR1 isolated by immunoprecipitation with anti-Flag antibody. Western blot analysis showed that Nck2 (43 kDa protein) binds to DDR1 in a
collagen-dependent manner (left panel). The presence of equal amounts of DDR1 and Nck2 was veriﬁed by sequential Western blotting of total
lysates (right panels). TCL: total cell lysate.
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ble and healthy but fail to lactate at parturition [40]. We rea-
soned therefore that the mammary gland epithelium is the
most appropriate tissue to further deﬁne the functional rele-
vance of the interaction between DDR1 and Nck2 or Shp-2.
To this end, mammary gland tissue sections from wild type
and DDR1-null mice after the onset of lactation (2 days post
partum, 2dpp) were stained with antibodies for Nck2 or
Shp-2. In wild type tissue, highest Nck2 expression was found
in focal membrane-proximal areas of luminal epithelial cells
(Fig. 5A, indicated by arrows). In contrast, Nck2 was diﬀusely
expressed throughout the cytoplasm in DDR1-null tissue
(Fig. 5B). This aberrant staining was speciﬁc for tissue from
lactating DDR1-null mice, since during pregnancy we ob-
served staining undistinguishable to wild type samples (data
not shown). Staining for Shp-2 clearly conﬁrmed its cytoplas-
mic localization, albeit no diﬀerence between wild type and
DDR1 knockout was apparent (Fig. 5 C and D). The aberrant
Nck2 distribution is most likely not caused by cytoskeletal
diﬀerences between knockout and wild type, since staining
for F-actin is similar in both cases (Fig. 5 E and F).
In summary, the current set of data places DDR1 upstream
of at least two phosphotyrosine-dependent interactions medi-
ated by the SH2 domains of Nck2 or Shp-2. In extension of ear-lier work, we show that the Nck2 and Shp-2 are critical
regulators for cell diﬀerentiation of mammary gland cells
[10,15].4. Discussion
With the current results, the lack of knowledge on signaling
molecules downstream of DDR1 is being alleviated. While a
plethora of phosphotyrosine-dependent downstream targets
are documented for other RTK, until now, no SH2 domain-
dependent substrate binding had been found for DDR1. Using
the cytoplasmic domain as the bait in a two-hybrid screen, we
identiﬁed Nck2 as a direct DDR1-interacting partner. This
interaction is mediated by the SH2 domain of Nck2, is strictly
dependent on the activation of the receptor by collagen and
was conﬁrmed using a number of diﬀerent human cell lines
overexpressing DDR1. Interestingly, we found stronger bind-
ing of the isolated SH2 domain to DDR1 than full-length
Nck2, suggesting that the sequences within the SH3 domains
may antagonize the DDR1/Nck2 complex formation.
Full-length DDR1 (c-isoform) has a total of 15 tyrosines in
its cytoplasmic region and a phosphopeptide mapping ap-
proach performed here suggests that several of these tyrosines
Fig. 3. Shp-2 binds to activated DDR1 via tyrosine-740. (A) Schematic representation of the DDR1 tyrosine kinase (left) and a list of potential
recognition sites around all 15 tyrosine within the cytoplasmic domain of the DDR1b isoform (right). The consensus sequence for Shp-2, Nck2 and
ShcA binding is shown below [35]. (B) DDR1 was expressed in 293 cells with or without Shp-2. Collagen-dependent binding of DDR1 to Shp-2 was
documented by anti-Shp-2 immunoprecipitation followed by anti-phosphotyrosine (top panel) or anti-DDR1 (lower panel) Western blotting.
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amino acid sequence pY-D-E-P had been identiﬁed as a con-
sensus binding site for the SH2 domain of Nck1, which has
a 68% overall identity to Nck2 [5,30]. However, no clear dis-
tinction between the binding preferences of Nck1 and Nck2
has yet been made. Within the DDR1 cytoplasmic tail, tyro-
sine-484 (Y-Q-E-P) closely matches the Nck consensus, how-
ever further experimental work is required to conﬁrm it as
an Nck2 binding site.
Biochemical and genetic evidence supports a central role
for the two Nck adapters in cell migration [5]. The generation
of knockout mice revealed that Nck1 and Nck2 have largely
redundant functions as neither of the single knockouts re-
sulted in a phenotypic alteration, while the Nck1/Nck2 dou-
ble knockout was lethal during early embryogenesis [4].
Both proteins can form a wide array of interactions and serve
as a link between cell surface receptors through its SH2 do-
main and a variety of eﬀectors using their SH3 domains.
Membrane recruitment of eﬀectors such as Sam68, Pak or
WASP trigger cytoskeletal remodeling, which results in in-
creased chemotaxis, migration, axon extension or invasion
[19]. Data analyzing DDR1 function in the mammary gland
are in support of a pro-migratory function of Nck2 down-stream of DDR1 because knockout mice show dramatically
reduced epithelial duct elongation and branching at puberty
[9,40]. During late pregnancy and at parturition, DDR1
potentially places Nck2 to speciﬁc locations within the mam-
mary epithelium, which may be essential for proper alveolo-
genesis and for maintenance of lactation (Fig. 5). In
leukocytes and glioma cells, overexpression of DDR1 results
in enhanced cellular migration and invasion [17,27]. Interest-
ingly, Nck2, but not Nck1, interacts with focal adhesion ki-
nase as well as with PINCH, a molecule associated with
integrin-linked kinase, during integrin-mediated cell adhesion
[10,34]. It is tempting to speculate that integrin and DDR1
signaling pathways intersect by utilizing Nck2 as common
adaptor molecule. This assumption is supported by the fact
that in the developing nervous system, a speciﬁc role of
Nck2 downstream of the TrkB tyrosine kinase and B-type
ephrins have been suggested where activation of the Nck2
pathway results in growth cone retraction [7,32]. Although
we have only started to address the speciﬁc role of Nck2
downstream of DDR1, cell-wounding experiments with pri-
mary embryonic ﬁbroblasts showed that cells lacking
DDR1 are severely impaired in migration and wound closure
(D.H.H.K., Y.H. and W.F.V., manuscript in preparation).
Fig. 4. Activated DDR1 phosphorylates Shp-2. (A) Co-transfection of Shp-2 with a panel of diﬀerent DDR1 point mutations was performed using
293 cells. Immunoprecipitation of DDR1 followed by anti-Shp-2 Western blotting identiﬁed tyrosine-740 as Shp-2 binding site (upper panel). Equal
expression of DDR1 wild type and mutants was veriﬁed by reprobing with a DDR1-speciﬁc antibody. (B) Shp-2 was immunoprecipitated from 293
cells transfected with DDR1 and the catalytically inactive mutant of Shp-2-C463A. Anti-phosphotyrosine Western blotting showed collagen-
dependent tyrosine phosphorylation of Shp-2 (left panel). Equal expression was veriﬁed by anti-Shp-2 blotting (right panel). (C) Flag-tagged DDR1
was immunoprecipitated fromMCF-7 cells and subjected to anti-Shp-2 Western blotting. We found endogenous Shp-2 binding to DDR1 in a ligand-
dependent manner.
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which was not found in the two-hybrid screen but using a bio-
informatics approach, is also a mediator of cell migration.
Since Shp-2 has two SH2 domains, as well as phosphotyrosine
phosphatase enzymatic activity and two C-terminal tyrosines
targeted by upstream kinases, its mode of regulation is even
more intricate [23,36,37]. Mutations in the gene coding for
Shp-2 were found in a number of human cancers, including
lung and colon tumors, as well as leukemias, neuroblastomas
and the genetic disorder Noonan-syndrome [3]. Depending
on the cellular context, binding of Shp-2 to activated growth
factor receptors can lead to dephosphorylation of a Ras-
GAP binding site, thereby attenuating Ras-GTP turnover
and enhancing Ras-mediated cell migration and proliferation
[23]. However, Shp-2-induced dephosphorylation of other sig-
naling intermediates, such as Stat5, a downstream mediator of
the interleukin, growth factor and prolactin receptors, can ter-
minate a signaling event [6]. Interestingly, in a separate study
we found that prolactin-induced Stat5 phosphorylation and
nuclear translocation is severely diminished in DDR1-null
mammary gland cells and tissues, while overexpression of
DDR1 enhanced Stat5 activity [9]. Therefore, our ﬁndings sug-
gest that Shp-2 downstream of DDR1 has a dual function in
the mammary gland: it triggers cell diﬀerentiation and migra-
tion during puberty and pregnancy while sustaining DDR1-
mediated signaling during lactation.
We show here that Shp-2 binds to phosphotyrosine-740 in
the cytoplasmic domain of DDR1 in a collagen-dependent
manner (Figs. 3A and 4A). The peptide sequence ISpYPML
neighboring tyrosine 740 matches well with the immuno-recep-tor tyrosine-based inhibitory motif (ITIM)-consensus sequence
[I/V/L]XpYXX[I/V/L] found in large a number of proteins,
many of them belonging to the immune receptor inhibitor
and cell adhesion receptor family [29]. Importantly, Shp-2
was found to associate with a diverse range of signal-regula-
tory receptors, including PECAM-1, FcgammaRIIb, SRPSs
and gp49B [18,24,33]. It is tempting to speculate that recruit-
ment of active Shp-2 into the DDR1 signaling complex also re-
sults in dephosphorylation of molecules within the complex,
thereby generating an inhibitory signal that limits cell prolifer-
ation or diﬀerentiation. Evidence from DDR1-null mice show-
ing hyperproliferative mammary gland tissue and enhanced
growth of mesangial cells in the absence of DDR1 is in support
of this hypothesis [8,40].
Our ﬁnding of enzymatic-inactive Shp-2 being phosphory-
lated upon collagen stimulation suggests that DDR1 recognize
one or both of the C-terminal phosphorylation sites in Shp-2,
which were found to serve as docking sites for the Grb2 and
Gab2 adaptor molecules [22,26,37]. Binding of Shp-2 to
DDR1 most likely enhances the enzymatic activity of the phos-
phatase, thereby directly triggering downstream events. In fu-
ture work we will address this by overexpressing the Shp-2
C463A mutant in normal and transformed breast epithelial
cells as well as by re-expressing the DDR1-Y740F mutant in
knockout cells.
In summary, the identiﬁcation of Nck2 and Shp-2 as direct
interaction partners of DDR1 sheds new light on the role of
this collagen receptor in maintaining the physiological role of
the mammary gland as well as on their potential function dur-
ing breast tumor invasion.
Fig. 5. Expression of Nck2 and Shp-2 in mammary gland tissue from
DDR1-null mice. The expression and localization of Nck2, Shp-2 and
actin in wild type and DDR1-null mouse mammary glands at 2 days
post partum were analyzed by immunoﬂuorescence. Note the diﬀuse
expression of Nck2 in DDR1-null tissue compared to the more deﬁned
expression in the wild type (arrows). Bars are 10 lm in length.
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